/COMUNICAE/
Medical Services Santa Cruz echoes the news released by Infosalus about the discovery of a new treatment for overweight with a drug for diabetes
Medical Services Santa Cruz, one in Sevilla treatment stomach reduction in Sevilla, echoes the information provided by the portal specialized in health news Infosalus. This news narrates the discovery of a new treatment against overweight. Treatment is based on a drug originally created for type 2 diabetes that reduces in a large percentage the weight of people who have been offered for the study.
The Tirzepatide drug is the cause of these advances in clinical trials to lose weight in people with obesity. The SURMOUNT-1 clinical trial is in its third phase, in which overweight volunteers from all over Europe have undergone treatment with positive results. The weight loss of these volunteers is 16% to 22.5%. People who have taken a placebo instead of the drug have only reached a weight loss of 5%. This clinical trial has had three study groups divided according to the amount of the drug ingested for 72 days.
This treatment is a surprising measure for the fight against overweight, increasingly common in the population, as previously there have been no such high weight loss rates with any other drug. With these advances, in addition to stomach reduction treatments and other variants, the fight against overweight is increasingly taking a more positive look. In addition, Tirzepatida has obtained good data in the studies for which it was initially created. This drug has been presented in conventions related to diabetes, giving excellent results in adults with type 2 diabetes. Therefore, this drug can become a very effective treatment for two common diseases of the current society.
Find a new treatment for overweight
Medical Services Santa Cruz echoes the news released by Infosalus about the discovery of a new treatment for overweight with a drug for diabetes /COMUNICAE/ /
nails
en
https://cdnimages.juegosboom.com/doityour.health/1220/dbmicrodb2-nails-find-a-new-treatment-for-overweight-723-0.jpg
2023-04-11
Acording with the Digital Millennium Copyright Act (“DMCA”), Pub. L. 105-304 If you believe that your copyrighted work is being infringed, notify our team at the email [email protected]